Zika virus outbreaks have now been recorded throughout Southeast Asia, the South Pacific, South America, and Central America. To protect the health of billions of people at risk and prevent future outbreaks, a team of Virginia Tech researchers recently received a $2 million R01 grant from the National Institutes of Health to develop a safe, effective, single-dose vaccine candidate for Zika virus.
Learn more here.